Niagen Bioscience (NASDAQ:NAGE) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.02 by 200 percent. This is a 700 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $30.48 million which beat the analyst consensus estimate of $27.10 million by 12.48 percent. This is a 37.59 percent increase over sales of $22.15 million the same period last year.